Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx

Radiotherapy and Oncology

Volumn 105, Issue 1, 2012, Pages 36-40

  Nyflot, Matthew J ^a   Harari, Paul M ^a   Yip, Stephen ^a   Perlman, Scott B ^a   Jeraj, Robert ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Correlation; Cu ATSM; FDG; FLT; PET

Indexed keywords

3' FLUOROTHYMIDINE F 18; DIACETYL BIS(N4 METHYLTHIOSEMICARBAZONE) CU 61; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; HUMAN; HYPOXIA; IMAGE ANALYSIS; OROPHARYNX CANCER; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VOXEL BASED MORPHOMETRY;

ADULT; AGED; BRAIN NEOPLASMS; CELL HYPOXIA; CELL PROLIFERATION; DIDEOXYNUCLEOSIDES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; OROPHARYNGEAL NEOPLASMS; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; THIOSEMICARBAZONES;

EID: 84868341360     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.09.012     Document Type: Article

References (30)

1. C.C. Ling, J. Humm, and S. Larson Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality Int J Radiat Oncol Biol Phys 47 2000 551 560
2. B. Vanderstraeten, W. Duthoy, W.D. Gersem, W.D. Neve, and H. Thierens [18F]Fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer Radiother Oncol 79 2006 249 258
3. K.S.C. Chao, W.R. Bosch, and S. Mutic A novel approach to overcome hypoxic tumor resistance. Cu-ATSM-guided intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 49 2001 1171 1182
4. E.G.C. Troost, J. Bussink, A.L. Hoffmann, O.C. Boerman, W.J.G. Oyen, and J.H.A.M. Kaanders 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors J Nucl Med 51 2010 866 874
5. F. Duprez, W. De Neve, W. De Gersem, M. Coghe, and I. Madani Adaptive dose painting by numbers for head-and-neck cancer Int J Radiat Oncol Biol Phys 80 2010 1045 1055
6. A.S. Allal, D.O. Slosman, T. Kebdani, M. Allaoua, W. Lehmann, and P. Dulguerov Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose Int J Radiat Oncol Biol Phys 59 2004 1295 1300
7. J-Fo Daisne, T. Duprez, and B. Weynand Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen Radiology 233 2004 93 100
8. V. Gregoire, K. Haustermans, X. Geets, S. Roels, and M. Lonneux PET-based treatment planning in radiotherapy: a new standard? J Nucl Med 48 2007 68S 77S
9. M. Nordsmark, S.M. Bentzen, and V. Rudat Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 2005 18 24
10. W.J. Koh, J.S. Rasey, and M.L. Evans Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole Int J Radiat Oncol Biol Phys 22 1992 199 212
11. Y. Fujibayashi, H. Taniuchi, Y. Yonekura, H. Ohtani, J. Konishi, and A. Yokoyama Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential J Nucl Med 38 1997 1155 1160
12. F. Dehdashti, P.W. Grigsby, M.A. Mintun, J.S. Lewis, B.A. Siegel, and M.J. Welch Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report Int J Radiat Oncol Biol Phys 55 2003 1233 1238
13. F. Dehdashti, M.A. Mintun, and J.S. Lewis In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM Eur J Nucl Med Mol Imaging 30 2003 844 850
14. 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study Dis Colon Rectum 51 2008 1641 1648
15. 62Cu-ATSM PET/CT as a predictor of response in head and neck cancer: a pilot study Ann Nucl Med 25 2011 339 345
16. J.R. Grierson, and A.F. Shields Radiosynthesis of 3′-deoxy- 3′-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo Nucl Med Biol 27 2000 143 156
17. H. Vesselle, J. Grierson, and M. Muzi In vivo validation of 3′deoxy-3′-[18F]fluorothymidine ([18F]FLT) as a proliferation imaging tracer in humans: correlation of [18F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors Clin Cancer Res 8 2002 3315 3323
18. Y. Menda, L.L. Boles Ponto, and K.J. Dornfeld Kinetic analysis of 3′-deoxy-3′-18F-fluorothymidine (18F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy J Nucl Med 50 2009 1028 1035
19. M.H. Cherk, S.S. Foo, and A.M.T. Poon Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-fluoromisonidazole and 18F-FDG PET J Nucl Med 47 2006 1921 1926
20. H. Hoshikawa, Y. Nishiyama, T. Kishino, Y. Yamamoto, R. Haba, and N. Mori Comparison of FLT-PET and FDG-PET for visualization of head and neck squamous cell cancers Mol Imaging Biol 13 2010 172 177
21. A. Linecker, C. Kermer, and I. Sulzbacher Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival Nuklearmedizin 47 2008 80 85
22. T. Yamamoto, Y. Seino, and H. Fukumoto Over-expression of facilitative glucose transporter genes in human cancer Biochem Biophys Res Commun 170 1990 223 230
23. P. Vera, P. Bohn, and A. Edet-Sanson Simultaneous positron emission tomography (PET) assessment of metabolism with (18)F-fluoro-2-deoxy-d-glucose (FDG), proliferation with (18)F-fluoro-thymidine (FLT), and hypoxia with (18)fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study Radiother Oncol 98 2011 109 116
24. J.G. Rajendran, D.C. Wilson, and E.U. Conrad [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression Eur J Nucl Med Mol Imaging 30 2003 695 704
25. D. Thorwarth, S.-M. Eschmann, F. Holzner, F. Paulsen, and M. Alber Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients Radiother Oncol 80 2006 151 156
26. T.G. Lohith, T. Kudo, and Y. Demura Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer J Nucl Med 50 2009 1948 1953
27. L. Zhang, A.S. Garden, and J. Lo Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy Int J Radiat Oncol Biol Phys 64 2006 1559 1569
28. S.R. Bowen, A.J. van der Kogel, M. Nordsmark, S.M. Bentzen, and R. Jeraj Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling Nucl Med Biol 38 2011 771 780
29. J.F. Eary, F. O'Sullivan, J. O'Sullivan, and E.U. Conrad Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome J Nucl Med 49 2008 1973 1979
30. D. Barbee, R. Flynn, J. Holden, R. Nickles, and R. Jeraj A method for partial volume correction of PET-imaged tumor heterogeneity using expectation maximization with a spatially varying point spread function Phys Med Biol 55 2010 221 236